ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples. OnkoSight AdvancedNGS testing provides targeted gene content that is aligned with the latest […]
Sexually transmitted infections or STIs, also referred to as sexually transmitted diseases or STDs, are common in men and women. April is STD/STI Awareness Month, so there is no time like the present to talk with your sexual partner(s) and get tested. Did You Know? There are approximately 20 million new STI cases each year […]
BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).